Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Meloxicam sodium
Drug ID BADD_D01375
Description Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve various types of pain, including pain caused by musculoskeletal conditions, osteoarthritis, and rheumatoid arthritis.[A190189] With a longer half-life than most other NSAIDS, it is a favorable option for those who require once-daily dosing. Meloxicam is available in oral, transdermal, and intravenous formulations. It is a preferential COX-2 inhibitor, purportedly reducing the risk of adverse gastrointestinal tract effects, however, this is a topic of controversy.[A190198,A190201]
Indications and Usage For symptomatic treatment of arthritis and osteoarthritis.
Marketing Status Prescription; Discontinued
ATC Code M01AC06
DrugBank ID DB00814
KEGG ID D00969
MeSH ID D000077239
PubChem ID 4051
TTD Drug ID D0G7FJ
NDC Product Code 0597-0030; 22365-116; 0615-8124; 51869-0008; 43063-396; 50090-5861; 54458-965; 60760-419; 61442-127; 63187-083; 63629-2019; 65841-051; 65862-098; 67296-1250; 68071-1994; 68071-2184; 68071-3030; 68382-050; 68382-051; 70518-0031; 71610-544; 80425-0041; 52119-003; 16571-776; 35356-808; 50090-5339; 50436-1124; 65841-050; 68071-1919; 68071-4987; 68788-7726; 68788-7904; 70518-0171; 71205-923; 71205-924; 29300-124; 50090-0986; 50268-526; 51655-577; 53002-1535; 53002-1537; 58118-1158; 63629-2020; 68788-9418; 70518-3023; 70934-010; 70954-077; 71610-516; 71610-580; 72865-137; 76282-153; 51552-1377; 53069-0790; 53104-7574; 43353-038; 43353-979; 55289-618; 61919-434; 61919-469; 64380-715; 64380-716; 71335-1956; 0597-0029; 49452-4402; 65862-223; 16571-777; 42708-007; 43063-395; 51407-611; 53002-2537; 61442-126; 67296-0583; 68180-501; 68180-502; 69097-158; 69097-159; 69344-206; 71335-0406; 71335-1888; 76420-039; 76420-043; 80425-0083; 0395-8154; 68225-112; 29300-125; 43063-401; 49999-869; 50268-525; 50436-1125; 60760-404; 60760-448; 63629-3248; 63629-3328; 67296-1317; 68071-1993; 68180-188; 70518-1828; 71335-1618; 71518-001; 17373-1157; 0615-8040; 56125-750; 65841-004; 70859-007; 55289-272; 63187-082; 68462-140; 70518-1299; 80425-0043; 80425-0045; 51927-0032; 59349-0003; 43353-127; 50090-5340; 51407-610; 51655-731; 60687-199; 68462-141; 69344-205; 70518-0039; 70518-0200; 71610-380; 71610-542; 71610-583; 72865-138; 80425-0042; 80425-0044; 17373-1158; 38779-2746; 58624-0430; 60592-994; 62938-0026; 68981-032; 42708-093; 50090-0985; 65862-097; 67296-1817; 68788-1701; 70954-076; 76282-152; 51869-0007; 53747-006; 72969-045; 45865-360; 50090-4896; 53002-2535; 54458-964; 63629-7966; 67296-0823; 68180-189; 70518-2631
Synonyms Meloxicam | Miloxicam | Parocin | Mobic | Mobicox | Mobec | Masflex | Movicox | Reumoxicam | Uticox | Movalis
Chemical Information
Molecular Formula C14H12N3NaO4S2
CAS Registry Number 71125-38-7
SMILES CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)[O-].[Na+]
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Infection11.01.08.002--Not Available
Influenza22.07.02.001; 11.05.03.001--Not Available
Influenza like illness08.01.03.010--
Insomnia17.15.03.002; 19.02.01.002--
Intestinal perforation07.04.06.002--Not Available
Jaundice23.03.03.030; 09.01.01.004; 01.06.04.004--Not Available
Joint effusion15.01.02.005--
Joint swelling15.01.02.004--Not Available
Laryngitis11.01.13.001; 22.07.03.001--
Leukopenia01.02.02.001--Not Available
Liver function test abnormal13.03.01.013--Not Available
Loss of consciousness17.02.04.004--Not Available
Malaise08.01.01.003--
Melaena24.07.02.013; 07.12.02.004--Not Available
Meningitis11.01.03.001; 17.06.03.001--
Meningitis aseptic17.06.03.002; 11.01.03.002--Not Available
Menopausal symptoms21.02.02.002--Not Available
Mood swings19.04.03.001--Not Available
Mouth ulceration07.05.06.004--Not Available
Muscle spasms15.05.03.004--
Musculoskeletal pain15.03.04.007--
Myalgia15.05.02.001--
Myocardial infarction02.02.02.007; 24.04.04.009--
Nasopharyngitis22.07.03.002; 11.01.13.002--Not Available
Nausea07.01.07.001--
Nephritis20.05.02.001--Not Available
Nervous system disorder17.02.10.001--Not Available
Nervousness19.06.02.003--Not Available
Oedema14.05.06.010; 08.01.07.006--Not Available
Oedema peripheral14.05.06.011; 08.01.07.007; 02.05.04.007--
The 4th Page    First    Pre   4 5 6 7    Next   Last    Total 7 Pages